ReviewCurrent urology reports2014
Prostate cancer nomograms: a review of their use in cancer detection and treatment.
Review in Current urology reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prediction models for prostate cancer to be used in the primary care setting: a systematic review.BMJ open · 2020Pooled it
- Utility of Lymphadenectomy in Prostate Cancer: Where Do We Stand?Journal of clinical medicine · 2022Review
- Associations between LncRNADiagnostics (Basel, Switzerland) · 2021Article
- Contemporary national trends in prostate cancer risk profile at diagnosis.Prostate cancer and prostatic diseases · 2020Article
- Diagnostic performance ofEuropean journal of nuclear medicine and molecular imaging · 2019Article
- Novel concepts for risk stratification in prostate cancer.Journal of clinical urology · 2016Article
- Can nomograms improve our ability to select candidates for active surveillance for prostate cancer?Prostate cancer and prostatic diseases · 2016Article
- Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.Future oncology (London, England) · 2016Review
- Post-operative nomogram for predicting freedom from recurrence after surgery in localised breast cancer receiving adjuvant hormone therapy.Journal of cancer research and clinical oncology · 2015Article
- sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients.Journal of experimental & clinical cancer research : CR · 2015Article
- Does prostate acinar adenocarcinoma with Gleason Score 3+3=6 have the potential to metastasize?Diagnostic pathology · 2014Article
- Random biopsy: when, how many and where to take the cores?World journal of urology · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As prostate cancer treatment discussions have grown more complex, increasing numbers of nomograms to guide decision-making have been found in the literature. Such nomograms can influence every step in the prostate cancer therapeutic process, from determining the need for biopsy to the need for adjuvant therapy. With a properly counseled patient who is aware of the limitations of nomograms, such tools assist in the shared decision-making that characterizes modern informed consent.
Indexed as
Identifiers
24452739What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.